Topics

Genentech Selects Affimed Target in Immunotherapy Alliance

04:35 EST 8 Nov 2019 | Contract Pharma

Genentech is responsible for clinical development and commercialization worldwide

Original Article: Genentech Selects Affimed Target in Immunotherapy Alliance

NEXT ARTICLE

More From BioPortfolio on "Genentech Selects Affimed Target in Immunotherapy Alliance"

Quick Search